The intrinsic and extrinsic effects of N-linked glycans on glycoproteostasis

Nature Chemical Biology

Volumn 10, Issue 11, 2014, Pages 902-910

  Hebert, Daniel N ^a   Lamriben, Lydia ^a   Powers, Evan T ^b   Kelly, Jeffery W ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; GLYCAN; GLYCOPROTEIN; POLYSACCHARIDE;

AMYLOIDOSIS; CYSTIC FIBROSIS; ENERGY TRANSFER; ENZYME MODIFICATION; GLYCOPROTEOSTASIS; HOMEOSTASIS; LYSOSOME STORAGE DISEASE; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; QUALITY CONTROL; REVIEW; SECRETORY PATHWAY; SOLUBILITY; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM;

GLYCOPROTEINS; HOMEOSTASIS; HUMANS; MODELS, MOLECULAR; POLYSACCHARIDES;

EID: 84921850497     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1651     Document Type: Review

References (99)

1. Kim, Y. E., Hipp, M. S., Bracher, A., Hayer-Hartl, M. & Hartl, F. U. Molecular chaperone functions in protein folding and proteostasis. Annu. Rev. Biochem. 82, 323-355 (2013).
2. Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W. & Balch, W. E. Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78, 959-991 (2009).
3. Walter, P. & Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science 334, 1081-1086 (2011).
4. Schröder, M. & Kaufman, R. J. The mammalian unfolded protein response. Annu. Rev. Biochem. 74, 739-789 (2005).
5. Apweiler, R., Hermjakob, H. & Sharon, N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473, 4-8 (1999).
6. Freeze, H. H., Chong, J. X., Bamshad, M. J. & Ng, B. G. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am. J. Hum. Genet. 94, 161-175 (2014).
7. Ruiz-Canada, C., Kelleher, D. J. & Gilmore, R. Cotranslational and posttranslational N-glycosylation of polypeptides by distinct mammalian OST isoforms. Cell 136, 272-283 (2009). Identification of a new active site subunit for the OST that is capable of modifying proteins post-translationally.
8. O'Conner, S. E. & Imperiali, B. A molecular basis for glycosylation-induced conformational switching. Chem. Biol. 5, 427-437 (1998).
9. Price, J. L. et al. N-glycosylation of enhanced aromatic sequons to increase glycoprotein stability. Biopolymers 98, 195-211 (2012).
10. Solá, R. J. & Griebenow, K. Effects of glycosylation on the stability of protein pharmaceuticals. J. Pharm. Sci. 98, 1223-1245 (2009).
11. Hebert, D. N. & Molinari, M. Flagging and docking: dual roles for N-glycans in protein quality control and cellular proteostasis. Trends Biochem. Sci. 37, 404-410 (2012).
12. Hoffmann, D. & Florke, H. A structural role for glycosylation: lessons from the hp model. Fold. Des. 3, 337-343 (1998).
13. Shental-Bechor, D. & Levy, Y. Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc. Natl. Acad. Sci. USA 105, 8256-8261 (2008).
14. Wormald, M. R. et al. The conformational effects of N-glycosylation on the tailpiece from serum IgM. Eur. J. Biochem. 198, 131-139 (1991).
15. Yamaguchi, H. Chaperone-like functions of N-glycans in the formation and stabilization of protein conformation. Trends Glycosci. Glycotechnol. 14, 139-151 (2002).
16. Chen, M. M. et al. Perturbing the folding energy landscape of the bacterial immunity protein Im7 by site-specific N-linked glycosylation. Proc. Natl. Acad. Sci. USA 107, 22528-22533 (2010).
17. Price, J. L. et al. Context-dependent effects of asparagine glycosylation on Pin WW folding kinetics and thermodynamics. J. Am. Chem. Soc. 132, 15359-15367 (2010).
18. Barb, A. W., Borgert, A. J., Liu, M., Barany, G. & Live, D. Intramolecular glycan-protein interactions in glycoproteins. Methods Enzymol. 478, 365-388 (2010).
19. Quiocho, F. A. Protein-carbohydrate interactions-basic molecular features. Pure Appl. Chem. 61, 1293-1306 (1989).
20. Lemieux, R. U. How water provides the impetus for molecular recognition in aqueous solution. Acc. Chem. Res. 29, 373-380 (1996).
21. Asensio, J. L., Arda, A., Canada, F. J. & Jimenez-Barbero, J. Carbohydrate-aromatic interactions. Acc. Chem. Res. 46, 946-954 (2013).
22. Gao, J., Bosco, D. A., Powers, E. T. & Kelly, J. W. Localized thermodynamic coupling between hydrogen bonding and microenvironment polarity substantially stabilizes proteins. Nat. Struct. Mol. Biol. 16, 684-690 (2009).
23. Krapp, S., Mimura, Y., Jefferis, R., Huber, R. & Sondermann, P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 325, 979-989 (2003).
24. Chen, W. et al. Structural and energetic basis of carbohydrate-aromatic packing interactions in proteins. J. Am. Chem. Soc. 135, 9877-9884 (2013).
25. Chavelas, E. A. & Garcia-Hernandez, E. Heat capacity changes in carbohydrates and protein-carbohydrate complexes. Biochem. J. 420, 239-247 (2009).
26. Wu, H., Lustbader, J. W., Liu, Y., Canfield, R. E. & Hendrickson, W. A. Structure of human chorionic gonadotropin at 2.6 Å resolution from MAD analysis of the selenomethionyl protein. Structure 2, 545-558 (1994).
27. Weis, W. I. & Drickamer, K. Structural basis of lectin-carbohydrate recognition. Annu. Rev. Biochem. 65, 441-473 (1996).
28. Petrescu, A. J., Milac, A. L., Petrescu, S. M., Dwek, R. A. & Wormald, M. R. Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology 14, 103-114 (2004). Very informative survey of the protein primary, secondary and tertiary structural environments that surround N-linked glycans based on a database of glycoprotein crystal structures.
29. Surleac, M. D. et al. in Glycosylation (ed. Petrescu, S. M.) 3-20 (InTech, 2012). Additional helpful survey of structural environment of N-linked glycans.
30. Nishio, M. The CH/π hydrogen bond in chemistry. Conformation, supramolecules, optical resolution and interactions involving carbohydrates. Phys. Chem. Chem. Phys. 13, 13873-13900 (2011).
31. Hanson, S. R. et al. The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc. Natl. Acad. Sci. USA 106, 3131-3136 (2009).
32. Culyba, E. K. et al. Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns. Science 331, 571-575 (2011). This article introduced the enhanced aromatic sequon, an N-glycosylated structural module that stabilizes the proteins in which it is found and appears to be glycosylated with unusually high efficiency by OST.
33. Price, J. L., Powers, D. L., Powers, E. T. & Kelly, J. W. Glycosylation of the enhanced aromatic sequon is similarly stabilizing in three distinct reverse turn contexts. Proc. Natl. Acad. Sci. USA 108, 14127-14132 (2011).
34. Wyss, D. F. et al. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science 269, 1273-1278 (1995).
35. Glozman, R. et al. N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J. Cell Biol. 184, 847-862 (2009).
36. Tam, B. M. & Moritz, O. L. The role of rhodopsin glycosylation in protein folding, trafficking, and light-sensitive retinal degeneration. J. Neurosci. 29, 15145-15154 (2009).
37. Nyfeler, B. et al. Identification of ERGIC-53 as an intracellular transport receptor of α1-antitrypsin. J. Cell Biol. 180, 705-712 (2008).
38. Caramelo, J. J. & Parodi, A. J. Getting in and out from calnexin/calreticulin cycles. J. Biol. Chem. 283, 10221-10225 (2008).
39. Kapoor, M. et al. Interactions of substrate with calreticulin, an endoplasmic reticulum chaperone. J. Biol. Chem. 278, 6194-6200 (2003).
40. Schrag, J. D. et al. The structure of calnexin, an ER chaperone involved in quality control of protein folding. Mol. Cell 8, 633-644 (2001).
41. Frickel, E. M. et al. TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain. Proc. Natl. Acad. Sci. USA 99, 1954-1959 (2002).
42. Kozlov, G. et al. Structural basis of carbohydrate recognition by calreticulin. J. Biol. Chem. 285, 38612-38620 (2010).
43. Hebert, D. N., Foellmer, B. & Helenius, A. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J. 15, 2961-2968 (1996).
44. Vassilakos, A., Cohen-Doyle, M. F., Peterson, P. A., Jackson, M. R. & Williams, D. B. The molecular chaperone calnexin facilitates folding and assembly of class I histocompatibility molecules. EMBO J. 15, 1495-1506 (1996).
45. Daniels, R., Kurowski, B., Johnson, A. E. & Hebert, D. N. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol. Cell 11, 79-90 (2003). Describes a detailed model for the molecular choreography for nascent glycoprotein maturation and its interaction with ER lectin chaperones.
46. Pearse, B. R. & Hebert, D. N. Lectin chaperones help direct the maturation of glycoproteins in the endoplasmic reticulum. Biochim. Biophys. Acta 1803, 684-693 (2010).
47. Pearse, B. R. et al. The role of UDP-Glc: glycoprotein glucosyltransferase 1 in the maturation of an obligate substrate prosaposin. J. Cell Biol. 189, 829-841 (2010).
48. Hebert, D. N., Foellmer, B. & Helenius, A. Glucose trimming and reglucosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell 81, 425-433 (1995).
49. Brockmeier, A., Brockmeier, U. & Williams, D. B. Distinct contributions of the lectin and arm domains of calnexin to its molecular chaperone function. J. Biol. Chem. 284, 3433-3444 (2009).
50. Wijeyesakere, S. J., Rizvi, S. M. & Raghavan, M. Glycan-dependent and -independent interactions contribute to cellular substrate recruitment by calreticulin. J. Biol. Chem. 288, 35104-35116 (2013).
51. Warren, G. & Mellman, I. Bulk flow redux? Cell 98, 125-127 (1999).
52. Kamiya, Y. et al. Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36. J. Biol. Chem. 283, 1857-1861 (2008).
53. Nichols, W. C. et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93, 61-70 (1998).
54. Hebert, D. N. & Molinari, M. In and out of the ER: protein folding, quality control, degradation, and related human diseases. Physiol. Rev. 87, 1377-1408 (2007).
55. Needham, P. G. & Brodsky, J. L. How early studies on secreted and membrane protein quality control gave rise to the ER associated degradation (ERAD) pathway: the early history of ERAD. Biochim. Biophys. Acta 1833, 2447-2457 (2013).
56. Ermonval, M., Kitzmuller, C., Mir, A. M., Cacan, R. & Ivessa, N. E. N-glycan structure of a short-lived variant of ribophorin I expressed in the MadIA214 glycosylation-defective cell line reveals the role of a mannosidase that is not ER mannosidase I in the process of glycoprotein degradation. Glycobiology 11, 565-576 (2001).
57. Frenkel, Z., Gregory, W., Kornfeld, S. & Lederkremer, G. Z. Endoplasmic reticulum-associated degradation of mammalian glycoproteins involves sugar chain trimming to Man6-5GlcNAc2. J. Biol. Chem. 278, 34119-34124 (2003).
58. Lederkremer, G. Z. & Glickman, M. H. A window of opportunity: timing protein degradation by trimming of sugars and ubiquitins. Trends Biochem. Sci. 30, 297-303 (2005).
59. Iannotti, M. J., Figard, L., Sokac, A. M. & Sifers, R. N. A. Golgi-localized mannosidase (MAN1B1) plays a non-enzymatic gatekeeper role in protein biosynthetic quality control. J. Biol. Chem. 289, 11844-11858 (2014).
60. Pan, S., Cheng, X. & Sifers, R. N. Golgi-situated endoplasmic reticulum α-1, 2-mannosidase contributes to the retrieval of ERAD substrates through a direct interaction with gamma-COP. Mol. Biol. Cell 24, 1111-1121 (2013). Provocative support for Man1B1 actually residing in the Golgi.
61. Rymen, D. et al. MAN1B1 deficiency: an unexpected CDG-II. PLoS Genet. 9, e1003989 (2013).
62. Hosokawa, N., Kamiya, Y., Kamiya, D., Kato, K. & Nagata, K. Human OS-9, a lectin required for glycoprotein ERAD, recognizes mannose-trimmed N-glycans. J. Biol. Chem. 284, 17061-17068 (2009).
63. Fujimori, T., Kamiya, Y., Nagata, K., Kato, K. & Hosokawa, N. Endoplasmic reticulum lectin XTP3-B inhibits endoplasmic reticulum-associated degradation of a misfolded α1-antitrypsin variant. FEBS J. 280, 1563-1575 (2013).
64. Yamaguchi, D., Hu, D., Matsumoto, N. & Yamamoto, K. Human XTP3-B binds to α1-antitrypsin variant null (Hong Kong) via the C-terminal MRH domain in a glycan-dependent manner. Glycobiology 20, 348-355 (2010).
65. Christianson, J. C., Shaler, T. A., Tyler, R. E. & Kopito, R. R. OS-9 and GRP94 deliver mutant α1-antitrypsin to the Hrd1-SEL1L ubiquitin ligase complex for ERAD. Nat. Cell Biol. 10, 272-282 (2008). A tour-de-force analysis of the interactome for ERAD machinery complexes.
66. Saeed, M. et al. Role of the endoplasmic reticulum-associated degradation (ERAD) pathway in degradation of hepatitis C virus envelope proteins and production of virus particles. J. Biol. Chem. 286, 37264-37273 (2011).
67. Cormier, J. H., Tamura, T., Sunryd, J. C. & Hebert, D. N. EDEM1 recognition and delivery of misfolded proteins to the SEL1L-containing ERAD complex. Mol. Cell 34, 627-633 (2009).
68. Ushioda, R. et al. ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER. Science 321, 569-572 (2008).
69. Hollien, J. & Weissman, J. S. Decay of endoplasmic reticulum-localized mRNAs during the unfolded protein response. Science 313, 104-107 (2006).
70. Mori, K. Signalling pathways in the unfolded protein response: development from yeast to mammals. J. Biochem. 146, 743-750 (2009).
71. Shoulders, M. D., Ryno, L. M., Cooley, C. B., Kelly, J. W. & Wiseman, R. L. Broadly applicable methodology for the rapid and dosable small molecule-mediated regulation of transcription factors in human cells. J. Am. Chem. Soc. 135, 8129-8132 (2013).
72. Shoulders, M. D. et al. Stress-independent activation of XBP1s and/or ATF6 reveals three functionally diverse ER proteostasis environments. Cell Rep. 3, 1279-1292 (2013).
73. Denzel, M. S. et al. Hexosamine pathway metabolites enhance protein quality control and prolong life. Cell 156, 1167-1178 (2014).
74. Bernasconi, R. & Molinari, M. ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER. Curr. Opin. Cell Biol. 23, 176-183 (2011).
75. Voeltz, G. K., Rolls, M. M. & Rapoport, T. A. Structural organization of the endoplasmic reticulum. EMBO Rep. 3, 944-950 (2002).
76. Chevet, E. et al. Phosphorylation by CK2 and MAPK enhances calnexin association with ribosomes. EMBO J. 18, 3655-3666 (1999).
77. Lynes, E. M. et al. Palmitoylation is the switch that assigns calnexin to quality control or ER calcium signaling. J. Cell Sci. 126, 3893-3903 (2013).
78. Brockmeier, A. & Williams, D. B. Potent lectin-independent chaperone function of calnexin under conditions prevalent within the lumen of the endoplasmic reticulum. Biochemistry 45, 12906-12916 (2006).
79. Zuber, C. et al. Immunolocalization of UDP-glucose: glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control. Proc. Natl. Acad. Sci. USA 98, 10710-10715 (2001).
80. Pearse, B. R., Gabriel, L., Wang, N. & Hebert, D. N. A cell-based reglucosylation assay demonstrates the role of GT1 in the quality control of a maturing glycoprotein. J. Cell Biol. 181, 309-320 (2008).
81. Frenkel, Z., Shenkman, M., Kondratyev, M. & Lederkremer, G. Z. Separate roles and different routing of calnexin and ERp57 in endoplasmic reticulum quality control revealed by interactions with asialoglycoprotein receptor chains. Mol. Biol. Cell 15, 2133-2142 (2004).
82. Klampfl, T. et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N. Engl. J. Med. 369, 2379-2390 (2013).
83. Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N. & Dwek, R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science 343, 1235681 (2014).
84. Perry, S. T. et al. An iminosugar with potent inhibition of dengue virus infection in vivo. Antiviral Res. 98, 35-43 (2013).
85. Butters, T. D., Dwek, R. A. & Platt, F. M. Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 15, 43R-52R (2005).
86. Jeyakumar, M., Dwek, R. A., Butters, T. D. & Platt, F. M. Storage solutions: treating lysosomal disorders of the brain. Nat. Rev. Neurosci. 6, 713-725 (2005).
87. Booth, C. & Koch, G. L. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell 59, 729-737 (1989).
88. Egan, M. E. et al. Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8, 485-492 (2002).
89. Van Goor, F. et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. USA 106, 18825-18830 (2009).
90. Rowe, S. M. & Verkman, A. S. Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harb. Perspect. Biol. 3, 1-15 (2013).
91. Balch, W. E., Roth, D. M. & Hutt, D. M. Emergent properties of proteostasis in managing cystic fibrosis. Cold Spring Harb. Perspect. Biol. 3, a004499 (2011).
92. Mu, T. W., Fowler, D. M. & Kelly, J. W. Partial restoration of mutant enzyme homeostasis in three distinct lysosomal storage disease cell lines by altering calcium homeostasis. PLoS Biol. 6, e26 (2008).
93. Mu, T. W. et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134, 769-781 (2008). Provides a powerful example of the potential utility for proteostasis regulators.
94. 2+ increases enhance mutant glucocerebrosidase proteostasis. Nat. Chem. Biol. 6, 424-432 (2010).
95. Ong, D. S. et al. FKBP10 depletion enhances glucocerebrosidase proteostasis in Gaucher disease fibroblasts. Chem. Biol. 20, 403-415 (2013).
96. Bouchecareilh, M., Hutt, D. M., Szajner, P., Flotte, T. R. & Balch, W. E. Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiency. J. Biol. Chem. 287, 38265-38278 (2012).
97. Di, X. J., Han, D. Y., Wang, Y. J., Chance, M. R. & Mu, T. W. SAHA enhances proteostasis of epilepsy-associated α1 (A322D) β2γ2 GABA (A) receptors. Chem. Biol. 20, 1456-1468 (2013).
98. Cui, J., Smith, T., Robbins, P. W. & Samuelson, J. Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses. Proc. Natl. Acad. Sci. USA 106, 13421-13426 (2009).
99. Banerjee, S. et al. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proc. Natl. Acad. Sci. USA 104, 11676-11681 (2007).